Call Us + 33 1 84 88 31 00

Article D1221-2 of the French Public Health Code

The remuneration paid by the employer to the donor in respect of his professional activity may be maintained during the time devoted to the donation without constituting payment within the meaning of article L. 1211-4, provided that the duration of the absence does not exceed the time required to travel between the place of work and the place of donation and, where applicable, to return, as well as for the…

Read More »

Article R1221-5 of the French Public Health Code

Before the pre-donation interview, the candidate fills in a questionnaire, the form and content of which are defined by a decision of the Director General of the Agence nationale de sécurité du médicament et des produits de santé (French Agency for the Safety of Medicines and Health Products), following advice from the Etablissement français du sang (French Blood Establishment) and the Armed Forces Blood Transfusion Centre. At the end of…

Read More »

Article D1221-6 of the French Public Health Code

The following biological analyses and screening tests are carried out for each donation of blood or blood components intended for the preparation of labile blood products for direct therapeutic use: 1° Erythrocyte blood grouping, which includes : a) Determination of ABO and Rh(D) groups, also known as Rh 1 (RH1) ; b) Determining the Rh phenotype: C(RH2), E(RH3), c(RH4) and e(RH5) and Kell(KEL1) for the first two donations; 2° Testing…

Read More »

Article D1221-8 of the French Public Health Code

Derogations from the provisions of articles D. 1221-6 and D. 1221-7 may be provided for by order of the Minister for Health, when blood or its components are collected with a view to preparing labile blood products intended for programmed autologous transfusion.

Read More »

Article D1221-10 of the French Public Health Code

An order of the Minister for Health may provide for : 1° Biological analyses and screening tests to be carried out for the selection of red cell donors intended to stimulate the synthesis of anti-D antibodies in Rh-immunised plasma donors with a view to the preparation of anti-D immunoglobulins; 2° Biological analyses and screening tests to be carried out for the selection of Rh-immunised plasma donors with a view to…

Read More »

Article D1221-12 of the French Public Health Code

By way of derogation from the provisions of articles D. 1221-6 to D. 1221-8, an order of the Minister for Health lays down the conditions under which, in order to meet overriding therapeutic needs or to take account of the rarity of certain erythrocyte blood groups, labile blood products for direct therapeutic use, prepared from blood or blood components which have not undergone all the tests and analyses mentioned in…

Read More »

Article D1221-13 of the French Public Health Code

Any blood establishment collecting blood and its components, which prepares labile blood products intended for the preparation of intermediate products or medicinal products derived from blood, is required to apply the tests and analyses referred to in 4° and in b, c, d, e, g and h of 5° of article D. 1221-6 to the corresponding samples. Blood or its components may only be used for the purposes mentioned in…

Read More »

Contact a French lawyer now

Contact a French Business Lawyer

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call us at +33 (0) 1 84 88 31 00 or send us an email.

Useful links

You have a question in French Business Law?

Our French business lawyers are here to help.
We offer a FREE evaluation of your case.
Call +33 (0) 1 84 88 31 00 or send us an email.

All information exchanged through this website will be communicated to lawyers registered with a French Bar and will remain confidential.